BENCHLING

FOUNDERS: Ashu Singhal, Sajith Wickramasekara (CEO)

EQUITY RAISED: $114 mil

ESTIMATED 2019 REVENUE: $21 mil

LEAD INVESTORS: Alkeon, Andreessen Horowitz, Benchmark, Menlo Ventures, Thrive Capital, Y Combinator

Wickramasekara was an undergrad at MIT when he came up with the idea for a cloud-based CRISPR design tool to help scientists. Eight years later, Regeneron, Gilead, Genentech and hundreds of other companies use its collaborative R&D software. As many customers rush to come up with vaccines and treatments for Covid-19, Benchling is on call as needed—but has also stopped pushing software updates to those whose projects require total lockdown.